Disclosed are compounds of the formula:or the pharmaceutically acceptable acid addition salts thereof wherein:n is an integer;R1 represents an organic or inorganic group;R2 represents halogen or C1-C6 alkyl;RN is an alkylene carrying a substituted piperazine, piperidine, or tetrahydropyridine; andR4 is hydrogen or C1-C6 alkyl, which compounds are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents.
2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands